iSTAR Medical
12
2
4
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.
Role: lead
A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma
Role: lead
STAR-LIFE: a Post-market Registry on MINIject
Role: lead
MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract
Role: lead
MINIject Global Long-Term Follow-up Study
Role: lead
MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool
Role: lead
MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool
Role: lead
MINIject Glaucoma Implant in European Patients
Role: lead
STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program
Role: lead
MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Role: lead
MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications
Role: lead
STARflo European Safety and Efficacy Study
Role: lead
All 12 trials loaded